Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain. It aims to develop eye drops for the treatment of retinal vascular diseases, including wet Age-Related Macular Degeneration (wAMD) and Diabetic Macular Oedema (DME) by exploiting alternative splicing of vascular endothelial growth factor (VEGF).